|
Originally published In Press as doi:10.1074/jbc.M108441200 on November 29, 2001
J. Biol. Chem., Vol. 277, Issue 6, 4024-4033, February 8, 2002
Many Type IIs Restriction Endonucleases Interact with Two
Recognition Sites before Cleaving DNA*
Abigail J.
Bath,
Susan E.
Milsom,
Niall A.
Gormley, and
Stephen E.
Halford
From the Department of Biochemistry, School of Medical Sciences,
University of Bristol, University Walk, Bristol BS8 1TD, United
Kingdom
Received for publication, August 31, 2001, and in revised form, November 26, 2001
 |
ABSTRACT |
Type IIs restriction endonucleases
recognize asymmetric DNA sequences and cleave both DNA strands at fixed
positions, typically several base pairs away from the recognition site.
These enzymes are generally monomers that transiently associate to form
dimers to cleave both strands. Their reactions could involve bridging interactions between two copies of their recognition sequence. To
examine this possibility, several type IIs enzymes were tested against
substrates with either one or two target sites. Some of the enzymes
cleaved the DNA with two target sites at the same rate as that with one
site, but most cut their two-site substrate more rapidly than the
one-site DNA. In some cases, the two sites were cut sequentially, at
rates that were equal to each other but that exceeded the rate on the
one-site DNA. In another case, the DNA with two sites was cleaved
rapidly at one site, but the residual site was cleaved at a much slower
rate. In a further example, the two sites were cleaved concertedly to
give directly the final products cut at both sites. Many type IIs
enzymes thus interact with two copies of their recognition sequence
before cleaving DNA, although via several different mechanisms.
 |
INTRODUCTION |
Over 3000 type II restriction endonucleases have been identified
to date (1). These enzymes recognize short DNA sequences, 4-8 bp long
and cleave both strands of the DNA at fixed locations in or near their
recognition sites (2). With one exception, BfiI (3), they
require Mg2+ or a similar divalent metal ion to cleave DNA
(4), although a few also require
AdoMet1 for maximal activity
(5). Many of the type II enzymes are homodimeric proteins that interact
symmetrically with palindromic DNA sequences, so that one active site
in the dimer is placed to cleave one strand of the DNA and the other
active site the equivalent phosphodiester bond in the opposite strand:
for example, EcoRV, BamHI, and BglI
(6-8). Enzymes of this sort cleave DNA with multiple target sites by
means of separate reactions at each site (9), although they can act
processively and migrate from one site to another by intramolecular
processes (10).
Several type II enzymes that recognize palindromic sequences differ
from the orthodox enzymes, because they have to interact with two
copies of their target sequence before they can cleave DNA (11, 12).
The latter include the type IIe enzymes, such as EcoRII,
NaeI, and Sau3AI (13-17), and the type IIf
enzymes, such as SfiI, SgrAI, Cfr10I,
and NgoMIV (18-21). Both the type IIe and IIf enzymes bind
two sites concurrently but the former cleave only one site per
turnover, whereas the latter cleave both sites concertedly within a
single turnover (22). Except for Sau3AI, a monomer in free
solution (17), the type IIe enzymes are dimers with two distinct
DNA-binding clefts, both of which bind the cognate DNA sequence but one
is an allosteric locus that activates DNA cleavage in the other cleft
(15, 16). In contrast, the type IIf enzymes are generally tetramers
with two identical surfaces for binding their palindromic sites, each
made from two subunits (18, 21).
The type II family contains another subgroup, the type IIs systems
(24). The type IIs endonucleases recognize asymmetric DNA sequences,
4-7 bp long, and cleave both strands at specific locations up to 20 bases away from their recognition site (1). Several hundred type IIs
enzymes have been identified, and those characterized to date are
monomers in solution (25-28). Hence, they cannot act in the same way
as the dimeric and tetrameric enzymes noted above.
The archetypal type IIs enzyme, FokI, consists of a
DNA-binding domain and a catalytic domain, which are connected by a
flexible linker (29). In the crystal structure of FokI bound
to DNA, the DNA-binding domain from a single monomer covers the entire recognition sequence, but the catalytic domain lies distant from the
DNA and interacts instead with the binding domain (30). The catalytic
domain has the function of cleaving only one phosphodiester bond, thus
posing a question: How does FokI cut both strands? However,
when crystallized in the absence of DNA, the structure showed two
monomers of FokI interacting with each other via their catalytic domains, with the two active sites organized like those in
the BamHI dimer (31). The dimerization is necessary for DNA cleavage. The rates of cleavage of a DNA with one FokI site
do not increase proportionally to increases in the enzyme concentration but instead increase more steeply, which suggests that more than one
molecule of the enzyme is needed for each cleavage event (32). In
addition, the catalytic domain of FokI cannot cleave DNA by itself, but it can enhance the activity of wild-type FokI,
probably by associating with the catalytic domain of the latter and
cleaving the second DNA strand (32). In the presence of
Ca2+ as a non-catalytic analogue of Mg2+, the
binding of FokI to DNA duplexes carrying the recognition sequence yields a complex containing two protomers of FokI
and two duplexes (33). Nevertheless, the pathway for the assembly of a
FokI dimer at its recognition site(s) has yet to be
established. The monomer bound to the recognition sequence (30) could
recruit a second monomer from solution or from elsewhere on either the same DNA molecule, in cis, or from another DNA molecule,
in trans (31, 32). DNA cleavage by FokI may thus
require a bridging interaction between two copies of its recognition
sequence (33). If so, it should be more active on a DNA with two sites
than on a DNA with one site, because interactions spanning two DNA
sites occur more readily in cis than in trans
(34).
Evidence also exists to suggest that a number of other type IIs enzymes
require two sites for their cleavage reactions. For example,
BspMI has a very low activity on a plasmid that has one BspMI site, but its cleavage of this plasmid is stimulated
by the addition of DNA molecules that have multiple BspMI
sites (14). Similarly, Eco57I can be stimulated to cleave
refractory sites by the addition of an oligonucleotide duplex that
carries its recognition sequence (35). In these cases, the activating
DNA may provide in trans a second site for the enzyme, which
then allows the enzyme to cleave the refractory site, as noted with several type IIe and type IIf nucleases (13-22).
The aim of this work was to investigate whether interactions with two
DNA sites are a general feature of the reactions of the type IIs
endonucleases, by testing several type IIs enzymes against plasmids
with either one or two copies of the relevant recognition sequence. The
orthodox type II enzymes cleave substrates with one or two sites at the
same rate, and the two sites in the latter are cleaved sequentially,
giving rise first to the singly cut DNA and then the doubly cut
products: If the enzyme has the same activity at each site on the
two-site DNA, the singly cut DNA accumulates to a maximum of 40% of
the total DNA before declining to the doubly cut product (19). On the
other hand, enzymes that require two copies of their recognition site
will usually cleave the two-site DNA faster than the one-site DNA (12).
This strategy also distinguishes the type IIe enzymes, which require
two sites but cleave only one of them, from the type IIf enzymes, which act concertedly at two sites (22). The accompanying paper (36) describes further studies on the mode of action of one type IIs enzyme,
BspMI, which interacts with two sites but by a different mechanism from the others described here.
 |
EXPERIMENTAL PROCEDURES |
Proteins--
FokI, purified to homogeneity, was a
gift from J. Bitinaite and I. Schildkraut (New England BioLabs,
Beverly, MA). BspMI was purified as in the accompanying
paper (36). The molar concentrations of FokI and
BspMI are given in terms of the monomeric and tetrameric forms of the proteins, respectively (25, 36). Eco57I was
purchased from MBI Fermentas (Vilnius, Lithuania) and Acc36I
from SibEnzyme (Novosibirsk, Russia). All other enzymes were from
New England BioLabs. Concentrations of the enzymes from commercial
sources are given in terms of units of enzyme activity, as defined by the supplier.
DNA--
Plasmids pBR322 (37), pAT153 (38), pNEB193 (New England
BioLabs), and pSKFok1 (from J. Bitinaite (32)) were manipulated by
standard procedures (39) to yield the plasmids shown in Fig. 1. The
constructions of these plasmids generally involved the cleavage of one
of the vectors noted above with two restriction enzymes; the isolation
of the requisite section of the vector by electrophoresis through
agarose; and the ligation of this fragment to a duplex made by
annealing two complimentary oligodeoxyribonucleotides (the duplexes had
5' single-strand extensions of four bases that matched the termini from
the digest of the vector). The ligation mixtures were used to transform
Escherichia coli HB101 (39), and the transformants
containing the desired construct were identified by restriction
analyses. The validity of the plasmids was confirmed by DNA sequencing
across the site of the insertion of the oligoduplex (University of
Bristol Sequencing Service). The transformants carrying the requisite
plasmid were cultured in M9 minimal media with 37 MBq/liter
[methyl-3H]thymidine, and the covalently
closed form of the plasmid was purified by density-gradient
centrifugations (18, 19). The preparations were largely the supercoiled
form of the monomeric plasmid with generally <10% dimer or nicked
open-circle DNA.
The oligonucleotides used in the above manipulations were pur-
chased from MWG Biotech Ltd. (Milton Keynes, UK) and had the following sequences: for the conversion of pBR322 (a plasmid with single sites for BsmBI, BsmI, SapI,
BsaI, and BsgI) to pML2 (a plasmid with two sites
for each of these enzymes (Fig. 1),
5'-AATTCGGAGACGGTGAATGCGCTCTTCCGCGAGACCCACCCTGCACCA-3' in
the top strand (consecutive recognition sites for BsmI and SapI are underlined) and
5'-AGCTTGGTGCAGGGTGGGTCTCGCGGAAGAGCGCATTCACCGTCTCCG-3' in the bottom (from left to right, recognition sites for
BsgI, BsaI, and BsmBI are underlined);
for the conversion of pNEB193 (one BpmI site) to pAB5 (two
BpmI sites), 5'-AATTGAGACCCACGCTCACCGGCTCCAGATT-3' in the
top strand and 5'-CGCGAATCTGGAGCCGGTGAGCGTGGGTCTC-3' in the
bottom (BpmI site underlined); for the conversion of pSKFok1 (one FokI site) to pSKFok2 (two FokI sites),
5'-GATCCCAAGGGGGATGTGCTGCAAGGCGATT-3' in the top strand
(FokI site underlined) and
5'-CTAGAATCGCCTTGCAGCACATCCCCCTTGG-3' in the bottom; to convert pAT153
(one BspMI site) to pNAG1 (two BspMI sites),
5'-AGCTGGCCATGCTGTCCAGGCAGGTAGATGAC-3' in the top strand and
5'-GATCGTCATCTACCTGCCTGGACAGCATGGCC-3' in the bottom (BspMI site underlined). Whether the recognition sequence is
located in the top or the bottom strand of the above duplexes
determines the orientation of that site in the plasmid. In all of the
plasmids constructed here, the two sites for each enzyme were in
directly repeated (head-to-tail) orientation.
A further plasmid, pSKFok3, was constructed by subjecting pSKFok2 to a
partial digest with PvuII and a complete digest with HincII, prior to re-circularization by blunt-end ligation.
This procedure removed one of the two FokI sites in pSKFok2,
the site originally present in pSKFok1, and leaves a single
FokI site, that introduced during the construction of
pSKFok2 (Fig. 1).
DNA Cleavage Reactions--
Restriction enzymes were assayed on
3H-labeled DNA (5-10 nM) in 200-µl
reactions, in the buffer and at the temperature advised by the
supplier. The following reaction buffers were used: buffer A, 20 mM Tris acetate (pH 7.9), 50 mM potassium
acetate, 10 mM magnesium acetate, 1 mM DTT, and
100 µg/ml BSA; buffer A+, as A with 80 µM AdoMet;
buffer B, 50 mM Tris-HCl (pH 7.9), 50 mM NaCl,
10 mM MgCl2, 1 mM DTT, and 100 µg/ml BSA; buffer C, as buffer B except for NaCl at 100 mM; buffer D, 20 mM HEPES (pH 8.0), 80 mM NaCl, 10 mM MgCl2, and 1 mM DTT. FokI was diluted before use in 10 mM Tris-HCl (pH 7.4), 50 mM KCl, 0.1 mM EDTA, 1 mM DTT, 200 µg/ml BSA, and 50%
(v/v) glycerol. BspMI was diluted before use in 20 mM HEPES (pH 8.0), 50 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 200 µg/ml BSA, 1 mM spermine, 0.2% (v/v) Triton X-100, and 20% (v/v)
glycerol. Enzymes from commercial sources were diluted in the buffers
advised by the supplier. A 15-µl aliquot of the reaction mixture was
removed before adding the enzyme and further aliquots taken at various
times after adding the enzyme. The samples were mixed immediately with
10 µl of stop mix (9) prior to electrophoresis through agarose under
conditions that separated the supercoiled substrate and each of the
reaction products. The segments of agarose that contained each DNA
species were analyzed by scintillation counting to evaluate the
concentration of each form of DNA at each time point (22).
DNA Methylation--
Following a procedure described previously
(5), 2 units of either BsgI or BpmI were added to
four parallel samples containing 2 µg of phage DNA in 20 mM Tris acetate (pH 7.9), 50 mM potassium acetate, 1 mM DTT, and 100 mg/ml BSA. One sample contained
no further components: the second was supplemented with 80 µM AdoMet; the third with 10 mM magnesium
acetate; and the fourth with both 80 µM AdoMet and 10 mM magnesium acetate. The samples were left for 1 h at
37 °C, prior to heating to 67 °C for 20 min and cooling on ice.
To the samples that lacked Mg2+, magnesium acetate was
added to a final concentration of 10 mM along with a second
aliquot of the same enzyme, and these were incubated for a further
period of 1 h at 37 °C. The samples were analyzed by
electrophoresis through agarose containing ethidium bromide, and the
extent of cleavage was assessed visually under UV illumination.
 |
RESULTS |
The objective of this study was to characterize the steady-state
reactions of several type IIs restriction endonucleases on plasmids
that have either one or two copies of the relevant recognition sites,
to identify whether the enzyme in question needs to interact with two
recognition sites before cleaving DNA. The type IIs endonucleases examined here, and their recognition sequences, are listed in Table
I. Plasmids with one copy of each of
these recognition sequences were already available (Table I), and these
were used to construct new plasmids with two copies of the requisite
sequence (Fig. 1 and Table I). In some
instances (Fig. 1a), the sequences around each site in the
two-site plasmid were identical for 2 or 3 bp immediately adjacent to
the recognition sequence (Table I). However, restriction endonucleases
can be influenced by the sequences flanking the recognition site (2),
and the type IIs enzymes may also be affected by the sequence
throughout the length of DNA between recognition and cleavage sites.
Consequently, wherever practicable (Fig. 1, b-d), the two
recognition sites had the same flanking sequences for 3 bp upstream
of the recognition site and for all of the downstream sequence to 2
bp beyond the sites of cleavage (Table I).
View this table:
[in this window]
[in a new window]
|
Table I
Enzymes and substrates
The name, source, and recognition sequence for the type IIs restriction
enzymes examined are listed, along with the plasmids that were used as
substrates for each enzyme. On the plasmids with two sites, the length
of DNA between the sites is noted, as is the length of flanking DNA
sequences on either side of each site that are identical at both sites.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 1.
Plasmid substrates. a,
pBR322, which contains one site for BsmBI, BsmI,
SapI, BsaI, and BsgI at the positions
indicated, was converted to pML2 by inserting between the
EcoRI and HindIII sites an oligonucleotide duplex
with a second copy of each site. b, pNEB193, which contains
one site for BpmI, was converted to pAB5 by inserting
between the EcoRI and AscI sites a duplex
containing a BpmI site. c, pSKFok1 has one
recognition site for FokI and was converted to a plasmid
with two sites, pSKFok2, by inserting a duplex between the
BamHI and XbaI sites; pSKFok3 was created from
pSKFok2 by using PvuII and HincII to delete the
segment of DNA carrying the FokI site originally present in
pSKFok1, so as to leave only the FokI site inserted during
the construction of pSKFok2. d, pAT153, which contains a
single BspMI site, was converted to pNAG1 by inserting
between the HindIII and BamHI sites a duplex
carrying a BspMI site.
|
|
In the plasmids with two sites for a given enzyme, the length of DNA
between the sites varied from 189 to 2134 bp (Table I), but this will
not be a significant factor in determining whether the enzyme can
interact with two sites. In supercoiled DNA, the juxtaposition of two
sites in three-dimensional space is largely independent of the length
of the DNA between the sites (40, 41). Because the recognition
sequences for type IIs enzymes are asymmetric, a further factor that
might affect the ability of a type IIs enzyme to interact with two
sites is the relative orientation of the sites, because several systems
that act at two DNA sites require sites in a specified orientation
(42). Preliminary experiments in this laboratory have revealed that both FokI and BspMI cleave substrates with two
sites in direct repeat at different rates from substrates with two
sites in inverted orientation (data not shown). Hence, to permit
comparisons between the enzymes studied here, the two-site substrates
all had sites in directly repeated orientation.
The FokI and BspMI enzymes were purified to
homogeneity and were studied under steady-state conditions, with the
enzyme at a known concentration below that of the substrate. Only a
small fraction of the DNA would then be bound to the enzyme at any time during the reaction, and the majority of the DNA products observed in
the course of the reaction are free species liberated from the enzyme.
The other enzymes were purchased from commercial sources and were
supplied at concentrations specified in terms of units of enzyme
activity: The molar concentrations of these proteins were not known.
However, whenever tested, the reaction velocities of these enzymes
increased as the number of units of enzyme added to the reaction
increased. Hence, it is likely that their reactions were also carried
out under steady-state conditions with the enzymes at lower
concentrations than the DNA.
DNA Cleavage by BsmBI, BsmI, BsaI, and SapI--
These enzymes
were selected as examples of type IIs nucleases that cleave DNA close
to their recognition sites, 1 bp away in one strand and 5 bp away in
the other (Table I). The target sites for these four enzymes occur once
in pBR322, and a plasmid with two copies of each recognition sequence
was constructed from pBR322 (Fig. 1a). The enzymes were
tested against 3H-labeled preparations of the two plasmids.
Samples were taken from the reactions at timed intervals and analyzed
as under "Experimental Procedures" to determine the concentrations
of the supercoiled substrate and all of the various reaction products
(Fig. 2).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
BsmBI on plasmids with one or two
recognition sites. The drawings indicate the various
forms of DNA that can exist during the reaction of a restriction enzyme
on circular DNA with either one (a) or two (b)
recognition sites: SC, supercoiled substrate; OC,
open-circle DNA cleaved in one strand; FLL, full-length
linear DNA cleaved in both strands at one site; L1 and
L2 (only in b), the two linear DNA products from
cutting both strands at both sites. The reactions contained 48 units/ml
BsmBI and 5 nM DNA (~90% supercoiled) in
buffer C at 55 °C. The DNA was: in a, pBR322 (which has
one BsmBI site); in b, pML2 (which has two
BsmBI sites). At timed intervals after adding the enzyme,
aliquots were removed from the reactions and analyzed as under
"Experimental Procedures" to obtain concentrations of the following
forms of DNA: , supercoiled substrate (marked SC on both
graphs); , open-circle DNA (marked OC); , full-length
linear DNA (marked FLL); , total DNA cut at both sites
(marked in b as L1/2).
|
|
BsmBI cleaved the supercoiled (SC) form of pBR322 directly
to the full-length linear (FLL) form, without the accumulation of any
of the nicked open-circle (OC) DNA during the course of the reaction
(Fig. 2a). Hence, BsmBI cuts its recognition site in both strands within a single DNA binding event. The plasmid with two
BsmBI sites was cleaved first at one site, to give the FLL
form, again without liberating any of the OC DNA; after a lag phase,
the remaining site was then cleaved in a separate reaction to yield the two final products, L1 and L2 (Fig. 2b). The
time course for the formation and decay of the FLL form during the reaction on the two-site substrate matches that expected for two separate reactions, with the intrinsic rate for cutting the first site
equal to that for the second (9, 19). In addition, the initial rate for
the consumption of the SC DNA with one BsmBI site was
similar to that for the substrate with two sites (Table II).
View this table:
[in this window]
[in a new window]
|
Table II
Reaction rates on one-site and two-site substrates
The reactions contained the enzyme at the concentration noted (units/ml
for enzymes from commercial suppliers; nM for pure
proteins) in 200 µl of buffer at the indicated temperature, and 5 nM DNA (except for FokI and Acc36I,
with 10 nM DNA). The DNA had either one or two copies of
the recognition sequence for the enzyme in question (Table I). Samples
were withdrawn from the reactions at various times (0-240 min) and
analyzed as in "Experimental Procedures" to determine the initial
rates for the decline in the concentration of the supercoiled
substrates (nM DNA consumed/min). The rates on both
substrates are noted here, as are the ratios of the rates on the
two-site over the one-site DNA and the relative rates for cutting each
site in the two-site substrates. The reaction schemes, A-D, are as
noted under "Discussion."
|
|
When BsmI, BsaI, and SapI were tested
against the plasmids with one or with two copies of their respective
recognition sites (reactions not shown), they all behaved in
essentially the same manner as that shown for BsmBI (Fig.
2). In particular, these enzymes cleaved the substrates with one and
two sites at similar rates (Table II (12)), and they cut the two-site
DNA by means of independent reactions at each site: In all cases, the
maximal yield of FLL DNA generated during the course of their reactions on the two-site substrate was again ~40% of the total DNA, which indicates similar rates for cutting the first and second sites. If
these enzymes had acted processively, first cutting one site and then
translocating to the second site without leaving the DNA molecule, the
maximal yield of the FLL DNA would have been <40% of the total (9,
19).
BsmBI, BsmI, BsaI, and SapI
all cleave DNA in the manner of an orthodox type II restriction enzyme,
such as EcoRV, BamHI, and BglI (9).
They cut both strands of the DNA at an individual recognition site in
one DNA binding event and that they cut two recognition sites in the
same DNA sequentially, first at one site and then in a separate
reaction at the second site.
DNA Cleavage by BsgI and BpmI--
In contrast to the type IIs
enzymes noted above, which cleave DNA close to their recognition sites,
BsgI and BpmI cut the DNA 16 and 14 bases away
from their target sites, in the "top" and "bottom" strands,
respectively (Table I). The recognition sequences for BsgI
and BpmI are both similar to that for Eco57I, CTGAAG(16/14) (see Table I), which also cleaves DNA 16 and 14 bp away
from its target site. The type IIs restriction-modification systems
require two methyltransferase activities, one for each strand of their
asymmetric recognition sites (43), but Eco57I differs from
most type IIs systems in that a single polypeptide carries both the
endonuclease and one of the methyltransferase activities (44). Both the
methyltransferase and the endonuclease activities of Eco57I
require AdoMet. Hence, during Eco57I reactions in the
presence of AdoMet, a fraction of the DNA is protected from the
endonuclease by methylation (5). BsgI and BpmI
have similar genetic organizations and homologous amino acid sequences to Eco57I.2 DNA
cleavage by BsgI is also stimulated by AdoMet,2
although BpmI has yet to be tested in this regard (1).
When the Eco57I endonuclease was tested against plasmids
with one or two Eco57I sites (not shown), the principal
product was the OC form of the DNA nicked in just one strand, and only
a small fraction of the DNA was cleaved in both strands at either one or both sites, presumably as a consequence of the competing nuclease and methyltransferase activities of this protein. It was therefore impossible to determine whether Eco57I has the same or a
higher activity on its two-site substrate compared with its one-site substrate. In contrast, both BsgI (Fig.
3) and BpmI (data not shown)
made double-strand breaks at each recognition site on both their
one-site and two-site substrates. In the presence of AdoMet, the
initial rate of consumption of the two-site substrate for BsgI was >20 times faster than that for the DNA with one
BsgI site (Table II). A possible explanation of this
behavior is that the BsgI site introduced into pBR322 to
create the DNA with two sites, pML2 (Fig. 1a), is more
susceptible to BsgI than the site in pBR322: It has a
different sequence between the recognition site and the sites of DNA
cleavage 16/14 bp away. To test this possibility, pML2 was cut with
another restriction enzyme to yield a linear fragment with two
BsgI sites. The initial reaction of BsgI on this
linear DNA yields different products depending on whether it occurs at
site 1, the original site in pBR322, or at site 2, the newly introduced
site (Fig. 4a). When the
linear DNA was used as a substrate for BsgI, >80% of the
initial cleavages occurred at the original site and <20% at the new
site (Fig. 4b). The BsgI site introduced in the
construction of pML2 is thus less, rather than more, susceptible than
the site in pBR322. Yet the presence of this additional site in the DNA
causes a major increase in the rate at which BsgI cleaves
its site from pBR322.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
BsgI on plasmids with one or two sites.
The reactions contained 1.2 units/ml BsgI and 5 nM DNA (~95% supercoiled) in buffer A+ at 37 °C. The
DNA was: in a, pBR322 (one BsgI site); in
b, pML2 (two BsgI sites). At timed intervals
after adding the enzyme, aliquots were removed from the reactions and
analyzed as before to obtain concentrations of the following forms of
DNA: , supercoiled substrate (marked SC on both graphs);
, open-circle DNA (marked OC); , full-length linear
DNA (marked FLL); , total DNA cut at both sites (marked
in b as L1/2).
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4.
BsgI on linear DNA with two
sites. a, the diagram shows two pathways for
the reactions of BsgI on AflIII-linearized pML2:
the linear DNA can be cut at site 1, the original site
present in pBR322, to yield fragments A and BC;
or at site 2, the additional site present in pML2, to yield
fragments AB and C; cleavage at whichever site is
not cut in the initial reaction then releases the three final products,
A, B, and C. The number by
each fragment indicates its size in bp. b, the reaction
contained 4 units/ml BsgI and 5 nM linearized
pML2 in buffer A+ at 37 °C. (Prior to the reaction, the SC form of
pML2 had been cleaved with AflIII to yield the linear DNA
with two BsgI sites at the positions indicated in
a.) At timed intervals, aliquots were removed from the
reaction, quenched with stop mix, and analyzed by electrophoresis
through agarose to separate all of the forms of the DNA shown in
a. The plot shows the concentrations of two partial
products: , BC, generated by cutting only site 1; , AB, generated
by cutting only site 2.
|
|
BsgI Thus Requires for Its Optimal Activity Two Copies of Its
Recognition Sequence in Cis--
However, the reaction profile of
BsgI on the two-site plasmid (Fig. 3b) indicates
a sequential process, with the enzyme first cleaving one site and then,
in a separate reaction, the remaining site. Moreover, the yield of FLL
DNA during the BsgI reaction on its two-site substrate, at
~40% of the total DNA, shows that the rate for cutting the residual
site is similar to that for the initial site. This profile is distinct
from those for the type IIe and the type IIf enzymes that interact with
two DNA sites but which, respectively, cut just one site or two sites
concertedly (22).
The reaction profiles of BpmI on its one-site and two-site
substrates (not shown) were like those for BsgI (Fig. 3).
The rate at which BpmI consumed the two-site substrate was
again much faster than that for the one-site substrate (Table II (12)).
BpmI and BsgI are thus clearly similar to each
other, but the enzymes were affected differently by AdoMet. The rates
at which BpmI cleaved its one-site and its two-site
substrates were not altered by the addition by AdoMet (data not shown).
In contrast, the omission of AdoMet from BsgI reactions
caused ~10-fold reductions in the rates at which it cleaved plasmids
with either one or two sites (data not shown). Nevertheless, although
AdoMet enhanced the rates of BsgI reactions, BsgI
still cleaved its two-site substrate in the absence of AdoMet ~20
times faster than its one-site substrate.
In further studies, BsgI and BpmI were incubated
with their DNA substrates in the presence of AdoMet but in the absence
of Mg2+, to determine whether they can methylate their
recognition sites, as noted previously with Eco57I (5).
However, the preincubations of the DNA with AdoMet and either
BsgI or BpmI failed to confer any protection of
the DNA against subsequent digestions of the DNA by these enzymes in
the presence of Mg2+ (data not shown). It thus seems that
neither the BsgI nor the BpmI endonucleases are
capable of methylating DNA, which presumably accounts for why their
reactions, unlike those of Eco57I, proceed to completion in
the presence of AdoMet.
DNA Cleavage by FokI--
The FokI endonuclease was
initially tested against two plasmids: one with a single recognition
site for the enzyme, pSKFok1 (32); and a second that was constructed
from pSKFok1 by inserting an additional FokI site to give
the two-site plasmid, pSKFok2 (Fig. 1c). FokI
cleaved the two-site substrate >10 times faster than the one-site
substrate (Figs. 5, a and
b; Table II). However, the reaction profile for
FokI on its two-site substrate (Fig. 5b) differed
from that for BsgI (Fig. 3b): the amount of FLL
DNA that accumulated during the course of the FokI reaction
on its two-site substrate, almost 80% of the total DNA, was much
larger than that with BsgI. Hence, FokI cleaves
its two-site substrate initially at one site, at a rapid rate, and then
at the remaining site at a much slower rate. To determine if this is
due to differences in the local sequences around each site, the site
originally present in pSKFok1 was deleted from pSKFok2 so as to leave a
second one-site plasmid with just the newly introduced site, pSKFok3
(Fig. 1c). When the new site was the only FokI
site in the plasmid, the DNA was cleaved at a slow rate (Fig.
5c), similar to that on the initial one-site plasmid (Table
II). The FokI endonuclease thus has no intrinsic preference
for one site in pSKFok2 over the other, yet the presence of both sites
in the same DNA results in the cleavage of one of the two sites at a
much faster rate than a single site in a one-site substrate. Moreover,
the amount of FLL DNA produced during the reaction of FokI
on pSKFok2 reached a maximum at ~8 nM, in considerable
excess of the molarity of the enzyme used here, 1 nM (Fig.
5b). The FLL form therefore cannot be an enzyme-bound intermediate on the pathway to the product cut at both sites but must
instead be liberated from the enzyme after cutting just one site. The
reaction profile of FokI on the two-site substrate is similar to that for a type IIe enzyme, where one site serves to activate the enzyme for DNA cleavage at a second site (22).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
FokI on plasmids with one or two
sites. The reactions contained 1 nM FokI
and 10 nM DNA in buffer A at 37 °C. The DNA was: in
a, pSKFok1 (~95% supercoiled), which has one
FokI site; in b, pSKFok2 (~85% supercoiled),
which has an additional FokI site; in c, pSKFok3
(~95% supercoiled), which has one FokI site, which was
introduced during the construction of pSKFok2 from pSKFok1. At timed
intervals after adding the enzyme, aliquots were removed from the
reactions and analyzed as before to obtain concentrations of the
following forms of DNA: , supercoiled substrate (marked
SC on all three graphs); , open-circle DNA (marked
OC); , full-length linear DNA (marked FLL);
, total DNA cut at both sites (marked in b as
L1/2).
|
|
The reactions of FokI on its one-site and two-site
substrates were also studied across a range of enzyme concentrations,
although keeping the enzyme at a lower concentration than the DNA so as to maintain steady-state conditions. To permit a comparison between the
one- and the two-site plasmids, the reaction velocities were measured
from the decline in the concentration of the SC substrate with time
rather than from the formation of the final products, because the final
products from the one- and the two-site substrates differ from each
other. As shown previously (32), the velocities of the FokI
reactions on a DNA with one FokI site did not increase linearly with the enzyme concentration but instead increased more steeply than expected for a linear dependence (Fig.
6a). When tested on the DNA
with two FokI sites, the reaction velocities again increased
with increasing enzyme concentration, by larger factors than expected
for a linear dependence (Fig. 6b). However, the extents to
which the increasing concentrations of FokI enhanced the
reaction velocities on the one-site substrate were similar to those on
the two-site substrate: The ratio of the rates on the two substrates
remained constant at ~10:1 across the range of FokI
concentrations.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
FokI concentration
dependences. The reactions contained 10 nM DNA in
buffer A at 37 °C and the concentration of FokI
indicated. The DNA was: in a, pSKFok1 (one FokI
site); in b, pSKFok2 (two FokI sites). For each
reaction, the initial rate for substrate utilization was measured as in
Fig. 5, and the values were plotted against the enzyme concentration
(due to the large difference in rates on the one- and two-site
substrates at each enzyme concentration tested, both x- and
y-scales in a differ from those in b).
The lines illustrate a linear increase in reaction rate with
enzyme concentration, from the value obtained at the lowest enzyme
concentration tested.
|
|
DNA Cleavage by BspMI and Acc36I--
BspMI cleaves certain
plasmids with a single copy of its recognition sequence at very low
rates, but it can be activated to cleave these plasmids by a second DNA
with multiple BspMI sites (14). The activation should be
more effective with two BspMI sites in cis, so
BspMI might cleave a DNA with two recognition sites more
rapidly than a DNA with one site. When tested against plasmids with
either one or two BspMI sites (Fig. 1d), the
plasmid with one site was indeed cleaved more slowly than that with two sites, as measured from the initial rate for the decline in the concentration of the respective substrates with time (Figs.
7, a and b). In
this respect, BspMI is similar to BsgI and
FokI, which also cleave their two-site substrates more
rapidly than their one-site substrates (Table II). However, the amount
of FLL DNA produced during the course of the BspMI reaction
on its two-site substrate (Fig. 7b) was much lower than had
been observed with either BsgI (Fig. 3b) or
FokI (Fig. 5b). With BspMI, the
initial rate for forming the FLL DNA cut at a single site was slower
than that for forming the two final products cut in both strands at both sites, L1 and L2. This contrasts to the behavior of both BsgI and FokI, which convert their two-site
substrates first to the DNA cut at one site and only later to the
products cut at both sites. BspMI thus acts on its two-site
substrate in a highly concerted manner, generally cleaving both strands
at both sites within a single DNA binding event so as to convert the
majority of SC plasmid directly to the final products L1 and L2. The
lack of FLL DNA during the BspMI reaction on its two-site
substrate could be due to processive action, but processivity cannot
account for why the rate of utilization of the two-site DNA is faster than that of the one-site DNA (9, 19). Hence, BspMI must follow the same mode of action as SfiI and the other type
IIf restriction enzymes (18-22).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7.
BspMI on plasmids with one or two
recognition sites. The reactions contained 0.25 nM
BspMI and 5 nM DNA (~90% supercoiled) in
buffer D at 37 °C. The DNA was: in a, pAT153 (one
BspMI site); in b, pNAG1 (two BspMI
sites). At timed intervals after adding the enzyme, aliquots were
removed from the reactions and analyzed to obtain concentrations of the
following forms of DNA: , supercoiled substrate (marked
SC on both graphs); , open-circle DNA (marked
OC); , full-length linear DNA (marked FLL);
, total DNA cut at both sites (marked in b as
L1/2).
|
|
Acc36I is an isoschizomer of BspMI with respect
to both its recognition sequence and its sites for DNA cleavage (Table
I) and might thus be expected to act in the same way as
BspMI. To see if this is so, the plasmids with one and two
BspMI sites (Fig. 1d) were re-used as substrates
for Acc36I. Like BspMI, Acc36I cleaved
the DNA with one site more slowly than that with two sites (Table II).
However, during its reaction on the two-site substrate (not shown),
Acc36I liberated much more of the FLL DNA than had been
observed in the BspMI reaction. The reaction profile of
Acc36I on its two-site substrate was similar to that of
BsgI (Fig. 3b), particularly with respect to the
kinetics for the formation and decay of the FLL form of the DNA during
the course of the reaction. Thus, rather than acting concertedly on DNA
with two sites, Acc36I cleaves its two-site substrate in the
same manner as BsgI: i.e., by means of two
kinetically separate reactions that have similar rates but which are
both faster than that on a DNA with a single site.
 |
DISCUSSION |
The orthodox type II restriction enzymes, such as BamHI
and EcoRV, are homodimeric proteins that, in most cases,
interact symmetrically with their palindromic recognition sequences (2, 12). The contacts between one subunit of the protein and one half of
the recognition sequence are usually, but not always, duplicated by the
second subunit with the other half of the DNA, and the two active sites
of the dimer are each positioned to cleave one strand of the DNA
(6-8). In contrast, the type IIs restriction enzymes have asymmetric
recognition sequences. It is difficult to imagine how two subunits of a
homodimeric enzyme could each recognize one half of an asymmetric
sequence. Instead, it is far more likely that the recognition of the
complete target sequence for a type IIs enzyme is achieved by a single
protein subunit. Moreover, many type IIs proteins are monomers in
solution (25-28). The question then arises as to how they are able to
cleave both DNA strands. It has been suggested that they may have two
active sites per monomer (24), but the crystal structure of
FokI shows that this is not the case, at least for this
particular enzyme (30). Each FokI monomer has the catalytic
functions for cutting just one strand, and it appears that
FokI has to dimerize before cleaving DNA (31-33).
In this study, the kinetics of DNA cleavage by several type IIs
restriction enzymes were examined under steady-state conditions, so as
to reveal the form(s) of the DNA liberated from the enzyme after each
turnover, as opposed to the enzyme-bound form(s). For each enzyme, two
substrates were used: one plasmid with a single recognition site for
the enzyme in question and another with two sites (Fig. 1; Table I).
Several, but not all, of the enzymes examined cleaved the plasmid with
two copies of the recognition site faster than the plasmid with one
copy, which indicates that the optimal activity of these enzymes
requires a bridging interaction between two DNA sites in cis
(9, 19). The enzymes that cleaved their two-site substrates more
rapidly than their one-site substrates showed a variety of different
reaction profiles on their two-site substrates, with respect to the
formation and decay of the FLL DNA cleaved at a single site. Among the
nine enzymes examined, four distinct reaction schemes were observed, as
judged from the rates at which they cleaved their one-site and two-site
substrates and the relative rates at which they cleaved each site on
the two-site plasmid. The four schemes are noted as A, B, C, and D (Table II).
Scheme A, BsmBI, BsmI, BsaI, and SapI--
One mode of action is
exemplified by BsmBI, BsmI, BsaI, and
SapI. All four of these enzymes cleaved their one-site
substrates directly to the FLL DNA, without liberating the nicked OC
form of the DNA cut in just one strand (Fig. 2a). Moreover,
these enzymes cleaved each site on their two-site substrates in
separate reactions (Fig. 2b), which both proceeded at the
same rate as that on the one-site substrate. Unlike the other type IIs
enzymes studied here, they do not need to interact with two sites.
Hence, BsmBI, BsmI, BsaI, and
SapI act in essentially the same manner as the orthodox type
II enzymes such as EcoRV and BglI (9). The
absence of OC DNA during their reactions show that they cut both
strands before dissociating from the DNA. This mode of action is,
however, difficult to reconcile to the general view that type IIs
restriction enzymes are monomeric proteins with the catalytic functions
for cutting one just strand.
One possibility is that BsmBI, BsmI,
BsaI, and SapI are monomeric proteins but with
two active sites per subunit, like the PI-SceI endonuclease
(45). Although some of the LAGLIDADG family of homing endonucleases are
homodimers with one copy of this active-site motif in each subunit, for
example I-CreI (46), others such as PI-SceI are
monomers with two active sites in one polypeptide, each with a copy of
the LAGLIDADG motif (45). Alternatively, BsmBI,
BsmI, BsaI, and SapI may be
homodimeric proteins with one active site in each subunit. If so, both
subunits might participate in the DNA cleavage reaction, although only
one would be involved in DNA recognition. A further possibility is that
these enzymes are composed of two different subunits, both of which
have catalytic functions but only one has the DNA-recognition
unit.3 To identify how these
enzymes operate, their subunit structures and active-site organizations
need to be determined, but such studies have yet to be conducted on any
one of these four enzymes.
The recognition sequences for BsmBI and BsaI
differ by just 1 bp whereas that for SapI is an extended
version of a similar sequence (Table I). Hence, the similarities in the
mode of action of BsmBI, BsaI, and
SapI may be due to familial relationships among these three
enzymes, like those between N.BstNBI,
MlyI, and PleI (28). BsmI also cleaves
DNA close to its recognition site. These four enzymes cleave one strand
just 1 bp away from the recognition site. Consequently, the
DNA-recognition and catalytic domains of these enzymes may not be
physically separate from each other, as is the case with
FokI (29, 30). The mode of action typified by
BsmBI may thus be common among the type IIs enzymes that
cleave DNA close to their recognition sites.
Scheme B, BsgI, BpmI, and Acc36I--
A second mode of
action for type IIs enzymes was found with BsgI and
BpmI and with Acc36I (Table II). These enzymes
cleaved their two-site substrates more rapidly than their one-site
substrates (Fig. 3), even when the site introduced to make the two-site
substrate was less susceptible to the enzyme than the site originally
present in the one-site DNA (Fig. 4). Hence, these enzymes require two copies of their recognition sites in cis for their optimal
DNA cleavage activities. However, having cut one site in their two-site substrates, BsgI and its kin cleave the residual site, not
at the rate characteristic of their reactions on a one-site DNA, but
instead at a similar rate to their initial reactions on the two-site
DNA: This is shown by the maximal yield of FLL DNA during their
reactions on two-site substrates (Fig. 3b). One explanation for this behavior stems from the fact that the type IIs enzymes cleave
the DNA away from their recognition sites, 16 and 14 bp away in the
case of BsgI and BpmI. The orthodox type II
enzymes usually destroy their recognition sequences by cutting the DNA within the sequence, but after a type IIs enzyme has cut one site in a
two-site substrate, the DNA still possesses two intact copies of the
recognition sequence. The activation of the enzyme by a second copy of
its recognition site may therefore still be achievable even after the
enzyme has cleaved the DNA downstream of that site. For the cleaved
locus to function as an activator, the energy from the interactions
with the DNA at the site of cleavage would need to be minor compared
with those at the recognition site.
The BsgI and BpmI endonucleases are similar to
Eco57I (5, 44) in terms of their recognition sequences (1),
their genetic organizations, and their amino acid
sequences2 and probably also in their mode of action.
Indeed, the activation of Eco57I by oligoduplexes requires
the duplex to contain the recognition site, but the downstream cleavage
site is not needed (35). Nevertheless, they seem to differ from each
other with respect to their responses to AdoMet. Although the
Eco57I protein functions as both a methyltransferase and an
endonuclease, with both activities requiring AdoMet, no methylation of
the DNA was observed here with either BsgI or
BpmI, and, of these two, only BsgI was stimulated
by AdoMet. These differences may be more apparent than real. During the
purification of DNA methyltransferases, AdoMet can remain bound to the
protein throughout the preparation (47). We cannot exclude the
possibility that the samples of BpmI used here contain a
stoichiometric amount of AdoMet, which might be sufficient for full
activation of the endonuclease but insufficient for multiple turnovers
of the methyltransferase. The mode of action of BsgI on DNA
with two recognition sites is, however, not unique to this particular
subset of type IIs enzymes, as the same mode was observed with
Acc36I (Table II). Yet Acc36I is an isoschizomer
of BspMI, an enzyme that behaves in a radically different
manner (see later and accompanying paper (36)).
Scheme C, FokI--
A third mode of action was noted with
FokI (Fig. 5). Like BsgI, FokI cleaved
the plasmid with two copies of its recognition site more rapidly than
plasmids with a single copy. The two single-site plasmids for
FokI, carrying either one of the sites present in the
two-site DNA, were both cleaved slowly so the enhanced rate on the DNA
with two sites must be due to the presence of two FokI sites
in the same molecule of DNA. The optimal activity of FokI therefore involves a bridging interaction between two copies of its
recognition sequence in cis. However, during the course of the FokI reaction on the DNA with two sites (Fig.
5b), the FLL DNA cleaved at one site accumulated to a higher
level than in the equivalent reaction with BsgI (Fig.
3b). The interaction of FokI with two DNA sites
in cis thus results in the rapid cleavage of just one site.
The other site presumably functions as an activator for DNA cleavage
rather than as a second substrate, in much the same way as with the
type IIe restriction enzymes. Indeed, the reaction profile of
FokI on its two-site substrate is very similar to that for
the type IIe enzyme NaeI (22).
One scheme for how the monomeric FokI protein might
interact concurrently with two DNA sites is that a monomer binds
separately to each site and that two monomers then associate to form
the dimer necessary for the DNA cleavage reaction (28, 31, 32). However, if this were the case, FokI should cleave a
two-site substrate faster than a one-site substrate only when the
enzyme is present at a higher concentration than the DNA. Otherwise, only a small fraction of the DNA will carry two monomers of the protein
at the same time. For example, with the enzyme at a 10-fold lower
concentration than the DNA (as in Fig. 5), then 1% of the DNA bound
to enzyme will carry two molecules of the enzyme. Yet, in contrast to
this scheme, enhanced activity on the two-site substrate was observed
here in reactions with excess DNA over protein. Moreover, the rates of
cleavage of the two-site substrate varied non-linearly with the
concentration of FokI in the same manner as those for the
cleavage of the one-site substrate (Fig. 6). This indicates that the
assembly of the active dimeric form of FokI occurs by the
same pathway on one-site and two-site substrates.
Rather than an association between two monomers that are each bound to
a separate recognition site, an alternative pathway is that a monomer
of FokI bound to one recognition site recruits a second
monomer from free solution. The crystal structure of the free
FokI protein shows a rather small dimer interface (31). The
complex containing two monomers at a single recognition site may
therefore be relatively unstable, and it may often fall apart before
cleaving the DNA, thus resulting in a relatively slow reaction velocity
on a DNA with one site. On the other hand, if the DNA has two sites,
the monomer recruited to the DNA-protein complex at one site will be
able to bind to the second site via its DNA-recognition domain and thus
stabilize the protein-protein association, in the same way as proposed
for the repressor (34). The complex spanning two sites may seldom
fall apart before cleaving the DNA, thus resulting in a much faster
reaction velocity on a DNA with two sites. In contrast to the pathway
involving the association of two DNA-bound monomers, this alternative
scheme can account for the variation in the cleavage rates on a
two-site substrate with the FokI concentration (Fig.
6b), but it requires that the FokI monomer has a
higher affinity for the protein bound to the recognition site than for
the vacant recognition site in the same DNA. Whether this is so has yet
to be determined.
Scheme D, BspMI--
The fourth mode of action was observed with
BspMI (Fig. 7). As with BsgI and FokI,
BspMI acted much more rapidly on the plasmid with two copies
of its recognition site than on that with one copy, but
BspMI gives a different reaction profile on its two-site substrate from either BsgI or FokI. The major
product(s) liberated from the BspMI protein during its
reaction on the DNA with two BspMI sites are the fragments
cut at both sites in both strands: Only a small fraction was liberated
from the enzyme as FLL DNA cut at one site. Hence, the binding of
BspMI to a DNA with two target sites generally results in
the cleavage of all four of the scissile phosphodiester bonds, two at
each target, before the enzyme dissociates from the DNA, although it
occasionally dissociates after cutting two bonds. The profile of the
steady-state reaction of BspMI on its two-site substrate is
thus similar to those of the tetrameric type IIf restriction
endonucleases, such as SfiI, Cfr10I, and
NgoMIV (18-22). Further studies, described in the
accompanying paper (36), show that BspMI is a tetramer that
has to bind to two copies of its recognition sequence before cleaving DNA.
This work has shown that the type IIs restriction enzymes display
considerable diversity in the mechanisms by which they cleave their DNA
substrates. This is in contrast to the orthodox type II restriction
enzymes that are often similar to one another in terms of structure
and/or reaction mechanism: viz. EcoRV and BglI (4, 6, 8, 9), and EcoRI and BamHI (7). Moreover, although some of the type II restriction enzymes that recognize palindromic DNA sequences have to interact with two copies of the
relevant recognition sequence before they can cleave DNA (11, 12), the
requirement for two sites seems to be particularly common, although not
universal, among the type IIs enzymes. Other type IIs enzymes that have
recently been shown to need two sites include MboII (48),
which follows scheme B, like BsgI (Fig. 3), and
BfiI,4 that yields
reaction profiles similar to those for scheme C, like FokI
(Fig. 5). The type I and III restriction enzymes also need two copies
of their recognition sites for most or all of their reactions (49).
Hence, a substantial fraction, perhaps the majority, of the restriction
enzymes that exist in nature are endonucleases that have to interact
with two sites before cleaving the DNA. The need for two sites can
enhance the ability of these enzymes to discriminate between cognate
and non-cognate DNA and to ensure that they cleave only the former
(23).
 |
ACKNOWLEDGEMENTS |
We thank Jurate Bitinaite, Ira Schildkraut,
Huimin Kong, and Geoff Wilson for advice and reagents; Bernard Connolly
and Virginijus Siksnys for pre-publication data; and Mark Szczelkun and
Lucy Daniels for comments.
 |
FOOTNOTES |
*
This work was supported by grants 7/G10881 from the
Biotechnology and Biological Sciences Research Council and 046178 from the Wellcome Trust.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 44-117-928-7429;
Fax: 44-117-928-8274; E-mail: s.halford@bris.ac.uk.
Published, JBC Papers in Press, November 29, 2001, DOI 10.1074/jbc.M108441200
2
H. Kong (New England BioLabs), personal communication.
3
G. Wilson (New England BioLabs), personal communication.
4
G. Sasnauskas and V. Siksnys (Institute of
Biotechnology, Vilnius), personal communication.
 |
ABBREVIATIONS |
The abbreviations used are:
AdoMet, S-adenosyl methionine;
DTT, dithiothreitol;
BSA, bovine
serum albumin;
SC, supercoiled;
OC, open-circle;
FLL, full-length
linear;
L1 and L2, linear DNA fragments from cutting a circular DNA
with two sites at both sites.
 |
REFERENCES |
| 1.
|
Roberts, R. J.,
and Macelis, D.
(2001)
Nucleic Acids Res.
29,
268-269[Abstract/Free Full Text]
|
| 2.
|
Roberts, R. J.,
and Halford, S. E.
(1993)
in
Nucleases
(Linn, S. M.
, Lloyd, R. S.
, and Roberts, R. J., eds)
, pp. 35-88, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 3.
|
Sapranauskas, R.,
Sasnauskas, D.,
Lagunavicius, A.,
Vilkaitis, G.,
Lubys, A.,
and Siksnys, V.
(2000)
J. Biol. Chem.
275,
30878-30885[Abstract/Free Full Text]
|
| 4.
|
Baldwin, G. S.,
Sessions, R. B.,
Erskine, S. G.,
and Halford, S. E.
(1999)
J. Mol. Biol.
288,
87-104[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Janulaitis, A.,
Petrusyte, M.,
Maneliene, Z.,
Klimasauskas, S.,
and Butkus, V.
(1992)
Nucleic Acids Res.
20,
6043-6049[Abstract/Free Full Text]
|
| 6.
|
Winkler, F. K.,
Banner, D. W.,
Oefner, C.,
Tsernoglou, D.,
Brown, R. S.,
Heathman, S. P.,
Bryan, R. K.,
Martin, P. D.,
Petratos, K.,
and Wilson, K. S.
(1993)
EMBO J.
12,
1781-1795[Medline]
[Order article via Infotrieve]
|
| 7.
|
Newman, M.,
Strzelecka, T.,
Dorner, L. F.,
Schildkraut, I.,
and Aggarwal, A. K.
(1995)
Science
269,
656-663[Abstract/Free Full Text]
|
| 8.
|
Newman, M.,
Lunnen, K.,
Wilson, G.,
Greci, J.,
Schildkraut, I.,
and Phillips, S. E. V.
(1998)
EMBO J.
17,
5466-5476[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Gormley, N. A.,
Bath, A. J.,
and Halford, S. E.
(2000)
J. Biol. Chem.
275,
6928-6936[Abstract/Free Full Text]
|
| 10.
|
Stanford, N. P.,
Szczelkun, M. D.,
Marko, J. F.,
and Halford, S. E.
(2000)
EMBO J.
19,
6546-6557[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Halford, S. E.,
Bilcock, D. T.,
Stanford, N. P.,
Williams, S. A.,
Milsom, S. E.,
Gormley, N. A.,
Watson, M. A.,
Bath, A. J.,
Embleton, M. L.,
Gowers, D. M.,
Daniels, L. E.,
Parry, S. H.,
and Szczelkun, M. D.
(1999)
Biochem. Soc. Trans.
27,
696-699[Medline]
[Order article via Infotrieve]
|
| 12.
|
Halford, S. E.
(2001)
Biochem. Soc. Trans.
29,
363-373[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Krüger, D. H.,
Barcak, G. J.,
Reuter, M.,
and Smith, H. O.
(1988)
Nucleic Acids Res.
16,
3997-4008[Abstract/Free Full Text]
|
| 14.
|
Oller, A. R.,
Vanden Broek, W.,
Conrad, M.,
and Topal, M. D.
(1991)
Biochemistry
30,
2543-2549[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Reuter, M.,
Kupper, D.,
Meisel, A.,
Schroeder, C.,
and Krüger, D. H.
(1998)
J. Biol. Chem.
273,
8294-8300[Abstract/Free Full Text]
|
| 16.
|
Huai, Q.,
Colandene, J. D.,
Topal, M. D.,
and Ke, H.
(2000)
Nat. Sruct. Biol.
8,
665-669
|
| 17.
|
Friedhoff, P.,
Lurz, R.,
Lüder, G.,
and Pingoud, A.
(2001)
J. Biol. Chem.
271,
23581-23588
|
| 18.
|
Wentzell, L. M.,
Nobbs, T. J.,
and Halford, S. E.
(1995)
J. Mol. Biol.
248,
581-595[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Bilcock, D. T.,
Daniels, L. E.,
Bath, A. J.,
and Halford, S. E.
(1999)
J. Biol. Chem.
274,
36379-36386[Abstract/Free Full Text]
|
| 20.
|
Siksnys, V.,
Skirgaila, R.,
Sasnauskas, G.,
Urbanke, C.,
Cherny, D.,
Grazulis, S.,
and Huber, R.
(1999)
J. Mol. Biol.
291,
1105-1118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Deibert, M.,
Grazulis, S.,
Sasnauskas, G.,
Siksnys, V.,
and Huber, R.
(2000)
Nat. Struct. Biol.
7,
792-799[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Embleton, M. L.,
Siksnys, V.,
and Halford, S. E
(2001)
J. Mol. Biol.
311,
503-515[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Embleton, M. L.,
Williams, S. A.,
Watson, M. A.,
and Halford, S. E.
(1999)
J. Mol. Biol.
289,
785-797[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Szybalski, W.,
Kim, S. C.,
Hasan, N.,
and Podhajska, A. J.
(1991)
Gene (Amst.)
100,
13-26[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Kaczorowski, T.,
Skowron, P.,
and Podhajska, A. J.
(1989)
Gene (Amst.)
80,
209-216[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Sektas, M.,
Kaczorowski, T.,
and Podajska, A. J.
(1992)
Nucleic Acids Res.
20,
433-438[Abstract/Free Full Text]
|
| 27.
|
Tucholski, J.,
Skowron, P.,
and Podjhaska, A. J.
(1995)
Gene (Amst.)
157,
87-92[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Higgins, L. S.,
Besnier, C.,
and Kong, H.
(2001)
Nucleic Acids Res.
29,
2492-2501[Abstract/Free Full Text]
|
| 29.
|
Li, L., Wu, L. P.,
and Chandrasegaran, S.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
4275-4279[Abstract/Free Full Text]
|
| 30.
|
Wah, D. A.,
Hirsh, J. A.,
Dorner, L. F.,
Schildkraut, I.,
and Aggarwal, A. K.
(1997)
Nature
388,
97-100[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Wah, D. A.,
Bitinaite, J.,
Schildkraut, I.,
and Aggarwal, A., K.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
10564-10569[Abstract/Free Full Text]
|
| 32.
|
Bitinaite, J.,
Wah, D. A.,
Aggarwal, A. K.,
and Schildkraut, I.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
10570-10575[Abstract/Free Full Text]
|
| 33.
|
Vanamee, E. S.,
Santagata, S.,
and Aggarwal, A. K.
(2001)
J. Mol. Biol.
309,
69-78[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Hochschild, A.
(1990)
in
DNA Topology and Its Biological Effects
(Cozzarelli, N. R.
, and Wang, J. C., eds)
, pp. 107-138, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 35.
|
Reuter, M.,
Kupper, D.,
Pein, C.-D.,
Petrusyte, M.,
Siksnys, V.,
Frey, B.,
and Krüger, D. H.
(1993)
Anal. Biochem.
209,
232-237[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Gormley, N. A.,
Hillberg, A.,
and Halford, S. E.
(2002)
J. Biol. Chem.
277,
4034-4041[Abstract/Free Full Text]
|
| 37.
|
Bolivar, F.,
Rodriguez, R. L.,
Greene, P. J.,
Betlach, M. C.,
Heyneker, H. L.,
Boyer, H. W.,
Crosa, J. H.,
and Falkow, S.
(1977)
Gene (Amst.)
2,
95-113[Medline]
[Order article via Infotrieve]
|
| 38.
|
Twigg, A. J.,
and Sherratt, D. J.
(1980)
Nature
283,
216-218[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Sambrook, J. C.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 40.
|
Huang, J.,
Schlick, T.,
and Vologodskii, A.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
968-973[Abstract/Free Full Text]
|
| 41.
|
Milsom, S. E.,
Halford, S. E.,
Embleton, M. L.,
and Szczelkun, M. D.
(2001)
J. Mol. Biol.
311,
517-528
|
| 42.
|
Stark, W. M.,
and Boocock, M. A.
(1995)
in
Mobile Genetic Elements
(Sherratt, D. J., ed)
, pp. 101-129, Oxford University Press, Oxford, UK
|
| 43.
|
Wilson, G. G.
(1991)
Nucleic Acids Res.
19,
2539-2565[Abstract/Free Full Text]
|
| 44.
|
Janulaitis, A.,
Vaisvila, R.,
Timinskas, A.,
Klimasauskas, S.,
and Butkus, V.
(1992)
Nucleic Acids Res.
20,
6051-6056[Abstract/Free Full Text]
|
| 45.
|
Christ, F.,
Schoettler, S.,
Wende, W.,
Steuer, S.,
Pingoud, A.,
and Pingoud, V.
(1999)
EMBO J.
18,
6908-6916[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Heath, P. J.,
Stephen, K. M.,
Monnat, R. J.,
and Stoddard, B. L.
(1997)
Nature Struct. Biol.
4,
468-476[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Szczelkun, M. D.,
and Connolly, B. A.
(1995)
Biochemistry
34,
10724-10733[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Soundararajan, M.,
Chang, Z.,
Morgan, R. D.,
Heslop, P.,
and Connolly, B. A.
(2001)
J. Biol. Chem.
277,
887-895[Abstract/Free Full Text]
|
| 49.
|
Rao, D. N.,
Saha, S.,
and Krishnamurthy, V.
(2000)
Prog. Nucleic Acids Res. Mol. Biol.
64,
1-63[Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Laurens, S. R. W. Bellamy, A. F. Harms, Y. S. Kovacheva, S. E. Halford, and G. J. L. Wuite
Dissecting protein-induced DNA looping dynamics in real time
Nucleic Acids Res.,
July 8, 2009;
(2009)
gkp570v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Morgan, E. A. Dwinell, T. K. Bhatia, E. M. Lang, and Y. A. Luyten
The MmeI family: type II restriction-modification enzymes that employ single-strand modification for host protection
Nucleic Acids Res.,
July 3, 2009;
(2009)
gkp534v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Lippow, P. M. Aha, M. H. Parker, W. J. Blake, B. M. Baynes, and D. Lipovsek
Creation of a type IIS restriction endonuclease with a long recognition sequence
Nucleic Acids Res.,
May 1, 2009;
37(9):
3061 - 3073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Sanders, L. E. Catto, S. R. W. Bellamy, and S. E. Halford
Targeting individual subunits of the FokI restriction endonuclease to specific DNA strands
Nucleic Acids Res.,
April 1, 2009;
37(7):
2105 - 2115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Morgan, T. K. Bhatia, L. Lovasco, and T. B. Davis
MmeI: a minimal Type II restriction-modification system that only modifies one DNA strand for host protection
Nucleic Acids Res.,
November 1, 2008;
36(20):
6558 - 6570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Catto, S. R. W. Bellamy, S. E. Retter, and S. E. Halford
Dynamics and consequences of DNA looping by the FokI restriction endonuclease
Nucleic Acids Res.,
April 1, 2008;
36(6):
2073 - 2081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gasiunas, G. Sasnauskas, G. Tamulaitis, C. Urbanke, D. Razaniene, and V. Siksnys
Tetrameric restriction enzymes: expansion to the GIY-YIG nuclease family
Nucleic Acids Res.,
February 11, 2008;
36(3):
938 - 949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kwiatek and A. Piekarowicz
The restriction endonuclease R.NmeDI from Neisseria meningitidis that recognizes a palindromic sequence and cuts the DNA on both sides of the recognition sequence
Nucleic Acids Res.,
October 8, 2007;
35(19):
6539 - 6546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-Y. Xu, Z. Zhu, P. Zhang, S.-H. Chan, J. C. Samuelson, J. Xiao, D. Ingalls, and G. G. Wilson
Discovery of natural nicking endonucleases Nb.BsrDI and Nb.BtsI and engineering of top-strand nicking variants from BsrDI and BtsI
Nucleic Acids Res.,
July 9, 2007;
35(14):
4608 - 4618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sukackaite, A. Lagunavicius, K. Stankevicius, C. Urbanke, C. Venclovas, and V. Siksnys
Restriction endonuclease BpuJI specific for the 5'-CCCGT sequence is related to the archaeal Holliday junction resolvase family
Nucleic Acids Res.,
April 1, 2007;
35(7):
2377 - 2389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Bist, U. K. Madhusoodanan, and D. N. Rao
A Mutation in the Mod Subunit of EcoP15I Restriction Enzyme Converts the DNA Methyltransferase to a Site-specific Endonuclease
J. Biol. Chem.,
February 9, 2007;
282(6):
3520 - 3530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Gemmen, R. Millin, and D. E. Smith
Tension-dependent DNA cleavage by restriction endonucleases: Two-site enzymes are "switched off" at low force
PNAS,
August 1, 2006;
103(31):
11555 - 11560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Gemmen, R. Millin, and D. E. Smith
DNA looping by two-site restriction endonucleases: heterogeneous probability distributions for loop size and unbinding force
Nucleic Acids Res.,
May 24, 2006;
34(10):
2864 - 2877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Catto, S. Ganguly, S. E. Milsom, A. J. Welsh, and S. E. Halford
Protein assembly and DNA looping by the FokI restriction endonuclease
Nucleic Acids Res.,
March 23, 2006;
34(6):
1711 - 1720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. v. d. Broek, F. Vanzi, D. Normanno, F. S. Pavone, and G. J.L. Wuite
Real-time observation of DNA looping dynamics of Type IIE restriction enzymes NaeI and NarI
Nucleic Acids Res.,
January 10, 2006;
34(1):
167 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Armalyte, J. M. Bujnicki, J. Giedriene, G. Gasiunas, J. Kosinski, and A. Lubys
Mva1269I: A Monomeric Type IIS Restriction Endonuclease from Micrococcus Varians with Two EcoRI- and FokI-like Catalytic Domains
J. Biol. Chem.,
December 16, 2005;
280(50):
41584 - 41594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Grazulis, E. Manakova, M. Roessle, M. Bochtler, G. Tamulaitiene, R. Huber, and V. Siksnys
Structure of the metal-independent restriction enzyme BfiI reveals fusion of a specific DNA-binding domain with a nonspecific nuclease
PNAS,
November 1, 2005;
102(44):
15797 - 15802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Gowers, G. G. Wilson, and S. E. Halford
From The Cover: Measurement of the contributions of 1D and 3D pathways to the translocation of a protein along DNA
PNAS,
November 1, 2005;
102(44):
15883 - 15888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Christensen and T. H. Eickbush
R2 Target-Primed Reverse Transcription: Ordered Cleavage and Polymerization Steps by Protein Subunits Asymmetrically Bound to the Target DNA
Mol. Cell. Biol.,
August 1, 2005;
25(15):
6617 - 6628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Peakman and M. D. Szczelkun
DNA communications by Type III restriction endonucleases--confirmation of 1D translocation over 3D looping
Nucleic Acids Res.,
August 9, 2004;
32(14):
4166 - 4174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Samuelson, Z. Zhu, and S.-y. Xu
The isolation of strand-specific nicking endonucleases from a randomized SapI expression library
Nucleic Acids Res.,
July 9, 2004;
32(12):
3661 - 3671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Gowers, S. R.W. Bellamy, and S. E. Halford
One recognition sequence, seven restriction enzymes, five reaction mechanisms
Nucleic Acids Res.,
June 29, 2004;
32(11):
3469 - 3479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mucke, D. H. Kruger, and M. Reuter
Diversity of Type II restriction endonucleases that require two DNA recognition sites
Nucleic Acids Res.,
November 1, 2003;
31(21):
6079 - 6084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hingorani-Varma and J. Bitinaite
Kinetic Analysis of the Coordinated Interaction of SgrAI Restriction Endonuclease with Different DNA Targets
J. Biol. Chem.,
October 10, 2003;
278(41):
40392 - 40399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. Kingston, N. A. Gormley, and S. E. Halford
DNA supercoiling enables the Type IIS restriction enzyme BspMI to recognise the relative orientation of two DNA sequences
Nucleic Acids Res.,
September 15, 2003;
31(18):
5221 - 5228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Protozanova, V. V. Demidov, P. E. Nielsen, and M. D. Frank-Kamenetskii
Pseudocomplementary PNAs as selective modifiers of protein activity on duplex DNA: the case of type IIs restriction enzymes
Nucleic Acids Res.,
July 15, 2003;
31(14):
3929 - 3935.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Sasnauskas, S. E. Halford, and V. Siksnys
How the BfiI restriction enzyme uses one active site to cut two DNA strands
PNAS,
May 27, 2003;
100(11):
6410 - 6415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Gormley, A. L. Hillberg, and S. E. Halford
The Type IIs Restriction Endonuclease BspMI Is a Tetramer That Acts Concertedly at Two Copies of an Asymmetric DNA Sequence
J. Biol. Chem.,
February 1, 2002;
277(6):
4034 - 4041.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|